Inspired by Nature.
Empowered by Technology.
Committed to Life.
Advancing Human-Relevant Systems to Reduce Reliance on Animal Models
Integrated • Predictive • Translational
Accelerating Smarter, More Human-Relevant Medicine
Video Gallery
Explore NAMina Bio’s latest videos, interviews, presentations, and visual updates on human-relevant translational research, advanced in-vitro technologies, and the future of New Approach Methodologies.
From scientific explainers to company milestones and event highlights, this gallery brings together the stories, technologies, and collaborations shaping NAMina Bio’s mission.
NAMina Bio | Building the Integration Layer for Human-Relevant Translational Evidence
NAMina Bio is building the integration layer for human-relevant translational evidence. In this short founder introduction, Dr. Paola Dama, Founder & CEO of NAMina Bio, shares the company’s vision: helping fragmented New Approach Methodologies — including organoids, organ-on-chip systems, dynamic 3D models, omics, imaging, and AI-enabled analytics — become standardized, comparable, and decision-ready.
Drug development still faces a major translational challenge. Advanced human-relevant technologies are emerging rapidly, but their outputs are often fragmented across platforms, partners, datasets, and experimental contexts. NAMina Bio is designed to close this orchestration gap. Through partner-enabled workflows, regulatory-aware evidence structuring, and the emerging NAMina Atlas™ intelligence framework, NAMina aims to support more organized, interpretable, and actionable preclinical decision-making.
NAMina Bio | From Static Models to Translational Workflows
In this video, NAMina Bio introduces how dynamic microenvironment and fluidic culture systems can be integrated into human-relevant translational workflows to support more biologically meaningful preclinical research. The presentation highlights NAMina Bio’s platform approach, connecting advanced 3D models, dynamic culture technologies, translational assay design, and data-driven interpretation to help academic, biotech, and pharma teams move beyond static in vitro models toward more decision-ready experimental systems. Topics include NAMina Bio’s pilot study framework, the role of dynamic culture systems in modeling physiologically relevant conditions, and how integrated workflows can support drug response profiling, resistance studies, tumor microenvironment modeling, and translational program design. This content is intended for research, collaboration, and educational purposes within the evolving New Approach Methodologies landscape.